Gsk (GSK) Non-Current Receivables (2009 - 2026)
Gsk (GSK) posted Non-Current Receivables of $181.4 million for Q4 2018, down 39.8% on a QoQ basis from $301.4 million in Q4 2017, and down 39.8% year-over-year from $301.4 million in Q4 2017.
Gsk (GSK) has 3 years of Non-Current Receivables data on file, last reported at $181.4 million in Q4 2018.
- In Q4 2018, Non-Current Receivables fell 39.8% year-over-year to $181.4 million; the TTM figure through Dec 2018 stood at $181.4 million (down 39.8% YoY), while the FY2018 annual figure was $188.3 million, down 35.6% from the prior year.
- Non-Current Receivables eased to $181.4 million in Q4 2018, from $301.4 million in the prior quarter.
- Across five years, Non-Current Receivables topped out at $353.1 million in Q4 2016 and bottomed at $181.4 million in Q4 2018.
- A 3-year average of $278.6 million and a median of $301.4 million in 2017 frame the typical range for Non-Current Receivables.
- Annual changes were most pronounced in 2017 — Non-Current Receivables slipped 14.64% — and 2018, when it tumbled 39.8%.
- Year by year, Non-Current Receivables stood at $353.1 million in 2016, then dropped by 14.64% to $301.4 million in 2017, then slumped by 39.8% to $181.4 million in 2018.
- The last three Non-Current Receivables figures came in at $181.4 million (Q4 2018), $301.4 million (Q4 2017), and $353.1 million (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.46 Bn |
| Dec 31, 2025 | 9.94 Bn |
| Sep 30, 2025 | 10.71 Bn |
| Jun 30, 2025 | 9.77 Bn |
| Mar 31, 2025 | 8.89 Bn |
| Dec 31, 2024 | 8.77 Bn |
| Sep 30, 2024 | 9.59 Bn |
| Jun 30, 2024 | 9.16 Bn |
| Mar 31, 2024 | 8.67 Bn |
| Dec 31, 2023 | 9.17 Bn |
| Sep 30, 2023 | 10.82 Bn |
| Jun 30, 2023 | 8.48 Bn |
| Mar 31, 2023 | 8.31 Bn |
| Dec 31, 2022 | 8.27 Bn |
| Sep 30, 2022 | 8.85 Bn |
| Jun 30, 2022 | 8.13 Bn |
| Mar 31, 2022 | 3.24 Bn |
| Dec 31, 2021 | 10.60 Bn |
| Sep 30, 2021 | 10.61 Bn |
| Jun 30, 2021 | 9.65 Bn |
| Mar 31, 2021 | 8.95 Bn |
| Dec 31, 2020 | 9.18 Bn |
| Jun 30, 2020 | 8.90 Bn |
| Mar 31, 2020 | 10.93 Bn |
| Dec 31, 2019 | 9.26 Bn |
| Sep 30, 2019 | 10.08 Bn |
| Jun 30, 2019 | 8.84 Bn |
| Mar 31, 2019 | 8.53 Bn |
| Dec 31, 2018 | 8.26 Bn |
| Sep 30, 2018 | 9.50 Bn |
| Jun 30, 2018 | 8.94 Bn |
| Mar 31, 2018 | 8.49 Bn |
| Dec 31, 2017 | 301.38 Mn |
| Sep 30, 2017 | 8.49 Bn |
| Jun 30, 2017 | 7.92 Bn |
| Mar 31, 2017 | 7.71 Bn |
| Dec 31, 2016 | 353.08 Mn |
| Sep 30, 2016 | 9.33 Bn |
| Jun 30, 2016 | 8.39 Bn |
| Mar 31, 2016 | 8.39 Bn |
| Dec 31, 2015 | 8.52 Bn |
| Sep 30, 2015 | 9.16 Bn |
| Jun 30, 2015 | 8.13 Bn |
| Mar 31, 2015 | 8.34 Bn |
| Dec 31, 2014 | 7.29 Bn |
| Sep 30, 2014 | 8.48 Bn |
| Jun 30, 2014 | 8.41 Bn |
| Mar 31, 2014 | 8.81 Bn |
| Dec 31, 2013 | 8.81 Bn |
| Sep 30, 2013 | 8.07 Bn |
| Jun 30, 2013 | 8.57 Bn |
| Mar 31, 2013 | 8.82 Bn |
| Dec 31, 2012 | 436.80 Mn |
| Sep 30, 2012 | 8.86 Bn |
| Jun 30, 2012 | 8.74 Bn |
| Mar 31, 2012 | 9.04 Bn |
| Dec 31, 2011 | 425.89 Mn |
| Sep 30, 2011 | 9.49 Bn |
| Jun 30, 2011 | 9.51 Bn |
| Mar 31, 2011 | 9.53 Bn |
| Dec 31, 2010 | 9.15 Bn |
| Sep 30, 2010 | 9.28 Bn |
| Jun 30, 2010 | 8.98 Bn |
| Mar 31, 2010 | 10.64 Bn |
| Dec 31, 2009 | 10.60 Bn |
| Sep 30, 2009 | 9.93 Bn |
| Jun 30, 2009 | 8.30 Bn |
| Mar 31, 2009 | 8.51 Bn |